within Pharmacolibrary.Drugs.ATC.B;

model B05XA01
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 7.666666666666667e-05,
    adminDuration  = 600,
    adminMass      = 20 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0005,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>B05XA01</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Potassium chloride is an electrolyte supplement used for the prevention and treatment of hypokalemia (low potassium levels). It is commonly administered orally or intravenously in clinical practice and is approved for use today.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adults, as literature describing compartmental PK models for potassium chloride is lacking. Potassium is an endogenous ion with rapid distribution, so a 1-compartment model is assumed for intravenous administration.</p><h4>References</h4><ol><li><p>Felker, GM, et al., &amp; O&#x27;Connor, CM (2011). Diuretic strategies in patients with acute decompensated heart failure. <i>The New England journal of medicine</i> 364(9) 797–805. DOI:<a href=\"https://doi.org/10.1056/NEJMoa1005419\">10.1056/NEJMoa1005419</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/21366472/\">https://pubmed.ncbi.nlm.nih.gov/21366472</a></p></li><li><p>Hoorn, EJ, &amp; Ellison, DH (2017). Diuretic Resistance. <i>American journal of kidney diseases : the official journal of the National Kidney Foundation</i> 69(1) 136–142. DOI:<a href=\"https://doi.org/10.1053/j.ajkd.2016.08.027\">10.1053/j.ajkd.2016.08.027</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27814935/\">https://pubmed.ncbi.nlm.nih.gov/27814935</a></p></li><li><p>DeCarolis, DD, et al., &amp; Ishani, A (2016). Comparative dose response using the intravenous versus enteral route of administration for potassium replenishment. <i>Intensive &amp; critical care nursing</i> 36 17–23. DOI:<a href=\"https://doi.org/10.1016/j.iccn.2015.08.005\">10.1016/j.iccn.2015.08.005</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26869280/\">https://pubmed.ncbi.nlm.nih.gov/26869280</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end B05XA01;
